SevenBridge Financial Group LLC Takes $229,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SevenBridge Financial Group LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 438 shares of the medical equipment provider’s stock, valued at approximately $229,000.

Other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $2,401,493,000. Proficio Capital Partners LLC lifted its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth about $313,769,000. Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $507.05 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $180.60 billion, a price-to-earnings ratio of 79.10, a PEG ratio of 5.85 and a beta of 1.43. The stock’s 50-day simple moving average is $550.11 and its 200-day simple moving average is $532.84.

Analysts Set New Price Targets

A number of research firms recently issued reports on ISRG. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Raymond James upped their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.